Cetirizine hydrochloride depression

Rx Drugs Bring Increased Risk for Depression Side Effect 

Getty Images

Hallie Levine,



En español

February 14, 2019

Medications are supposed to make you feel better. That’s one of the reasons why more than 40 percent of people over age 65 regularly take at least five different prescription drugs. But many drugs, including those commonly used to treat high blood pressure, heartburn and anxiety, can cause depression, according to a University of Illinois at Chicago study published in the Journal of the American Medical Association (JAMA) last June.

The study's authors found that about 200 prescription drugs, including some commonly used in older adults such as proton pump inhibitors (PPIs) to treat acid reflux and beta-blockers for hypertension, can cause depression. (About one-third of all Americans take at least one of these medications.)

They also found that the more drugs people took, the higher their risk: About seven percent of patients taking just one had depression compared to 15. 3 percent of patients taking at least three of them. Even more concerning, “Many physicians may not be aware that several commonly prescribed medications are associated with an increased risk of depression,” says study coauthor Mark Olfson, M.D., professor of psychiatry and epidemiology at the Columbia University Irving Medical Center. As a result, they’re not screening these patients for depression or educating them about the disease. 

For expert tips to help feel your best, get AARP’s monthly Health newsletter.

That doesn’t mean that anyone who takes one of these drugs will automatically become depressed — most older adults taking these drugs don’t, reassures Sunny Linnebur, a clinical pharmacy specialist for the University of Colorado Hospital Seniors Clinic and spokesperson for the American Geriatrics Society. But it does mean you should be vigilant for depression if you’re taking one or more of these medications. Here’s what you need to do:

Keep tabs on your mood

It’s normal to feel down from time to time. But if you’re experiencing a depressed mood most of the time for at least two weeks, you should see your doctor. Other symptoms to watch for include loss of interest in normally pleasurable activities, changes in appetite or weight, insomnia or sleeping too much, feeling exceptionally fatigued, trouble concentrating, feeling worthless and recurrent thoughts of death or suicide. Don’t wait for your doctor to bring up the topic at your next checkup, either. Less than two percent of doctor visits include screening for depression.

Review your meds

If you are depressed, ask your doctor to sit down and go through all of your drugs, and their potential side effects, with you. “Primary care physicians often practice under considerable time pressure,” stresses Olfson. “Once a patient is identified as having depression, patients are commonly presented with options of either starting antidepressants or psychotherapy.” But it’s crucial that doctors also take into account all the drugs you’re taking, he says, because one or more may be contributing to your depression.

If your physician doesn’t seem well-versed in each drug’s side effects, or seems reluctant to do so, ask your pharmacist, who should be very familiar with them, suggests Linnebur. If you have Medicare Part D, this visit may even be covered once a year as part of your medication management.

Keep in mind that after doing this, the cause of depression can still be a very hard issue to tease out. Your primary care physician or pharmacist can do some guesswork by asking you some questions and adjusting your medications, but in some cases, you may need to be referred to a psychiatrist who likely has the most in-depth knowledge of the mood-altering side effects of your medications, says Igor Galynker, M.D., professor of psychiatry at the Icahn School of Medicine at Mount Sinai in New York City.

Make some tweaks

If your medication does seem to be the cause, you may not need to stop taking it — you may simply be able to lower the dosage. If that’s not possible, the next step is to try to switch to another class of medications, says Linnebur. That may mean trying another blood pressure drug, for example, or if you’re on another potentially mood-altering medication such as corticosteroids, trying to get your inflammation symptoms under control with an over-the-counter pain reliever such as ibuprofen.

If there’s really no way for you to safely stop taking a medication, then you’ll need to figure out other ways to treat your depression with your doctor. Sometimes lifestyle changes alone will make a difference. A review published earlier this month in Psychosomatic Medicine found that depressed patients who lost weight, ate a healthy diet (high in fiber, low on processed foods) and exercised regularly were able to reduce symptoms of depression and anxiety.

Being culturally engaged also helps: A study published last December in The British Journal of Psychiatry found that folks who saw films, plays or visited a museum at least once a month had 48 percent lower risk of developing depression. But if that doesn’t work, you may need talk therapy or even medication, says Linnebur.

Flowers & Gifts


25% off sitewide and 30% off select items

See more Flowers & Gifts offers >

Know the top ten

These Rx medications are among the most commonly prescribed drugs that can cause depression in adults, according to the JAMA study.

  • Beta-blockers to treat high blood pressure such as metoprolol, atenolol, enalapril, and quinapril.
  • Anti-anxiety medications such as alprazolam (Xanax and generic), clonazepam (Klonopin and generic), diazepam (Valium and generic) and lorazepam (Ativan and generic) as well as the sedative zolpidem (Ambien and generic).
  • Opioids such as hydrocodone (Norco, Vicodin, Lorcet and generic), tramadol (Ultram, ConZip and generic).
  • Corticosteroids such as cortisone, hydrocortisone or prednisone, which are used to treat a variety of conditions including asthma, lupus and rashes.
  • Over-the-counter proton pump inhibitors omeprazole (Prilosec, Zegerid and generic) and esomeprazole (Nexium and generic) as well as over-the-counter antacids ranitidine (Zantac and generic) and famotidine (Pepcid and generic).
  • Certain allergy and asthma medications. The over-the-counter allergy medication cetirizine (Zyrtec and generic) has been linked to depression, as has another type of drug, montelukast (Singulair), which is often used to treat people with allergic asthma.
  • Anticonvulsant medications such as gabapentin (Neurontin and generic) and topiramate (Topamax and generic).
  • Amitriptyline to treat nerve pain and prevent migraine headaches.
  • Hormonal drugs. Estradiol (Delestrogen, Elestrin, EstroGel and generic), commonly used to treat menopausal symptoms and finasteride (Proscar, Propecia and generic), a medication used to treat an enlarged prostate and/or hair loss in men.

More on health

Common Drugs Increase Risk of Dementia

Disease can occur up to 20 years after exposure

Older Adults Have a Harder Time Beating Depression

Study finds greatest severity among adults 70+


Assessment of the effects of antihistamine drugs on mood, sleep quality, sleepiness, and dream anxiety

Randomized Controlled Trial

. 2014 Aug;18(3):161-8.

doi: 10. 3109/13651501.2014.907919. Epub 2014 Apr 23.

Pinar Guzel Ozdemir  1 , Ayşe Serap Karadag, Yavuz Selvi, Murat Boysan, Serap Gunes Bilgili, Adem Aydin, Sevda Onder



  • 1 Department of Psychiatry, Yuzuncu Yil University Medicine Faculty , Van , Turkey.
  • PMID: 24673474
  • DOI: 10.3109/13651501.2014.907919

Randomized Controlled Trial

Pinar Guzel Ozdemir et al. Int J Psychiatry Clin Pract. 2014 Aug.

. 2014 Aug;18(3):161-8.

doi: 10.3109/13651501.2014.907919. Epub 2014 Apr 23.


Pinar Guzel Ozdemir  1 , Ayşe Serap Karadag, Yavuz Selvi, Murat Boysan, Serap Gunes Bilgili, Adem Aydin, Sevda Onder


  • 1 Department of Psychiatry, Yuzuncu Yil University Medicine Faculty , Van , Turkey.
  • PMID: 24673474
  • DOI: 10.3109/13651501.2014.907919


Objective: There are limited comparative studies on classic and new-generation antihistamines that affect sleep quality and mood. The purpose of this study was to determine and compare the effects of classic and new-generation antihistamines on sleep quality, daytime sleepiness, dream anxiety, and mood.

Methods: Ninety-two patients with chronic pruritus completed study in the dermatology outpatient clinic. Treatments with regular recommended therapeutic doses were administered. The effects of antihistaminic drugs on mood, daytime sleepiness, dream anxiety, and sleep quality were assessed on the first day and 1 month after.

Results: Outpatients who received cetirizine and hydroxyzine treatments reported higher scores on the depression, anxiety, and fatigue sub-scales than those who received desloratadine, levocetirizine, and rupatadine. Pheniramine and rupatadine were found to be associated with daytime sleepiness and better sleep quality. UKU side effects scale scores were significantly elevated among outpatients receiving pheniramine. Classic antihistamines increased daytime sleepiness and decreased the sleep quality scores. New-generation antihistamines reduced sleep latency and dream anxiety, and increased daytime sleepiness and sleep quality.

Conclusion: Both antihistamines, significantly increased daytime sleepiness and nocturnal sleep quality. Daytime sleepiness was significantly predicted by rupadatine and pheniramine treatment. Cetirizine and hydroxyzine, seem to have negative influences on mood states. Given the extensive use of antihistamines in clinical settings, these results should be more elaborately examined in further studies.

Keywords: Antihistamines; daytime sleepiness; dream anxiety; mood; sleep quality.

Similar articles

  • Night-time sedating h2 -antihistamine increases daytime somnolence but not treatment efficacy in chronic spontaneous urticaria: a randomized controlled trial.

    Staevska M, Gugutkova M, Lazarova C, Kralimarkova T, Dimitrov V, Zuberbier T, Church MK, Popov TA. Staevska M, et al. Br J Dermatol. 2014 Jul;171(1):148-54. doi: 10.1111/bjd.12846. Epub 2014 May 26. Br J Dermatol. 2014. PMID: 24472058 Free PMC article. Clinical Trial.

  • Brain histamine h2 receptor occupancy measured by PET after oral administration of levocetirizine, a non-sedating antihistamine.

    Hiraoka K, Tashiro M, Grobosch T, Maurer M, Oda K, Toyohara J, Ishii K, Ishiwata K, Yanai K. Hiraoka K, et al. Expert Opin Drug Saf. 2015 Feb;14(2):199-206. doi: 10.1517/14740338.2015.989831. Epub 2014 Dec 3. Expert Opin Drug Saf. 2015. PMID: 25466429 Clinical Trial.

  • Central effects of fexofenadine and cetirizine: measurement of psychomotor performance, subjective sleepiness, and brain histamine h2-receptor occupancy using 11C-doxepin positron emission tomography.

    Tashiro M, Sakurada Y, Iwabuchi K, Mochizuki H, Kato M, Aoki M, Funaki Y, Itoh M, Iwata R, Wong DF, Yanai K. Tashiro M, et al. J Clin Pharmacol. 2004 Aug;44(8):890-900. doi: 10.1177/0091270004267590. J Clin Pharmacol. 2004. PMID: 15286093 Clinical Trial.

  • Second-generation antihistamines for the treatment of chronic idiopathic urticaria.

    Belsito DV. Belsito DV. J Drugs Dermatol. 2010 May;9(5):503-12. J Drugs Dermatol. 2010. PMID: 20480793 Review.

  • Antihistamines in dermatology.

    Greaves MW. Greaves MW. Skin Pharmacol Physiol. 2005 Sep-Oct;18(5):220-9. doi: 10.1159/000086667. Epub 2005 Jul 5. Skin Pharmacol Physiol. 2005. PMID: 16015020 Review.

See all similar articles

Cited by

  • Old versus new antihistamines: Effects on cognition and psychomotor functions.

    Shamil KS, Prakruti PP, Anuradha MG, Bela JS, Chetna KD. Shamil KS, et al. J Family Med Prim Care. 2022 Oct;11(10):5909-5917. doi: 10.4103/jfmpc.jfmpc_77_22. Epub 2022 Oct 31. J Family Med Prim Care. 2022. PMID: 36618177 Free PMC article.

  • Histamine and histamine receptors: Roles in major depressive disorder.

    Qian H, Shu C, Xiao L, Wang G. Qian H, et al. Front Psychiatry. 2022 Sep 23;13:825591. doi: 10.3389/fpsyt.2022.825591. eCollection 2022. Front Psychiatry. 2022. PMID: 36213905 Free PMC article. Review.

  • Impaired sleep quality in children with allergic conjunctivitis and their parents.

    Li J, Zhang SY, Fan Z, Liu R, Jin L, Liang L. Li J, et al. Eye (Lond). 2022 Jul 22. doi: 10.1038/s41433-022-02182-4. Online ahead of print. Eye (Lond). 2022. PMID: 35869391

  • Ameliorative Effect of a Neoteric Regimen of Catechin plus Cetirizine on Ovalbumin-Induced Allergic Rhinitis in Rats.

    Morsy MA, Patel SS, Bakrania A, Kandeel M, Nair AB, Shah JN, Akrawi SH, El-Daly M. Morsy MA, et al. Life (Basel). 2022 May 31;12(6):820. doi: 10.3390/life12060820. Life (Basel). 2022. PMID: 35743851 Free PMC article.

  • Frequently reported adverse events of rebamipide compared to other drugs for peptic ulcer and gastroesophageal reflux disease.

    Jang E, Park M, Jeong JE, Lee JY, Kim MG. Jang E, et al. Sci Rep. 2022 May 12;12(1):7839. doi: 10.1038/s41598-022-11505-0. Sci Rep. 2022. PMID: 35552457 Free PMC article.

See all "Cited by" articles

Publication types

MeSH terms


Page not found | Attending Doctor is a professional medical publication for physicians. Science articles.

  • Categories
  • Specializations
  • Authors


  • Allergology
  • Bronchopulmonology
  • Vaccination
  • Gastroenterology
  • Hepatology
  • Gynecology
  • Dermatovenereology
  • Immunology
  • infections
  • Cardiology
  • ENT pathology
  • Medical equipment
  • Urgent Care
  • Nutriciology
  • Oncology
  • Pediatrics
  • Psychoneurology
  • Rheumatology
  • seasonal allergies
  • Therapy
  • Uronephrology
  • Pharmacology
  • Endocrinology
  • IT in healthcare

Calendar of events:

  • 04

    VIII All-Russian Online Conference with international participation "Modern strategies for the treatment of immunoinflammatory diseases in the practice of a therapist - an emphasis on safety" end date: 05 March 2023 Venue: St. Petersburg, Moskovsky pr. 97A, Holiday Inn Moskovskie Vorota hotel (Pasternak hall, 3rd floor) and online on the Doctor at Study platform

  • 10

    Scientific-practical conference "Diagnosis, prevention and treatment of all patients with nephrological diseases" end date: 10 March 2023 Venue: Moscow, st. Novy Arbat, 36, building of the Government of Moscow, conference hall A + C

  • 14

    20th Pharmacy Summit "Effective Pharmacy Chain Management" end date: 14 March 2023 Venue: Moscow, Marriott Imperial Plaza Hotel (+online)

  • 15

    Child growth: the period from 1 year to 3 years: a series of RMANPE webinars end date: 15 March 2023 Venue: Online

  • 16

    Interregional scientific and practical conference with international participation "Topical issues of disaster medicine" end date: 17 March 2023 Venue: Tula, Atrium of the Tula Kremlin

The active ingredient is CETIRIZINE (CETIRIZINUM) | Compendium


CAS No: 83881-51-0 C 21 H 25 ClN 2 O 3

90686 MeSH, RTECS: (2-(4-((4-chlorophenyl)phenylmethyl)-1-piperazinyl)ethoxy)acetic acid.

M m = 388.90 Da. Melting point - 112.5 ° C. log P (octanol-water) = -0.61. White crystalline powder, soluble in water.

Presentation: drops and oral solution, syrup, p/o tablets, film-coated tablets.

  • Pharmacological properties
  • Indications CETIRIZINE
  • Application of CETIRIZINE
  • Contraindications
  • Side effects
  • Special instructions
  • Overdose
  • Diagnosis
  • Recommended alternatives
  • Trading names

Medicines containing the active substance cetirizine

Allertek ®

tablets covered with a shell of 10 mg, No. 7, 20

Polf AO

Price in pharmacies

AMER2 film-coated tablets 10 mg blister, № 20


Prices in pharmacies

Zodak ®

tablets covered with a shell 10 mg blister, No. 30



& bottle 20 ml, No. 1

Opella Healthcare Ukraine

Prices in pharmacies

Rolinose oral drops

oral drops, solution 10 mg/ml vial 20 ml in carton, No. 1

Pharmacy prices

Cetrin ®

film-coated tablets 10 mg blister, no. 20, 30

Dr. Reddy's Laboratories Ltd

Prices in pharmacies

cetirizine is an antiallergic agent, a blocker of peripheral H 1 receptors. Inhibits allergic reactions with the introduction of histamine, specific allergens, with cold urticaria. Reduces histamine-induced bronchoconstriction in asthma. Practically no effect on adreno- and 5-HT receptors, no effect on the central nervous system. The effect appears 2 hours after ingestion and persists for more than 24 hours.

seasonal and perennial allergic conjunctivitis, chronic idiopathic urticaria, eczema, angioedema, pruritus.

by mouth for adults and children 12 years of age and older: 10 mg once daily or 5 mg twice daily.

Learn more